Clinical Trial Update: Lactobacillus Reuteri ProGastria in Helicobacter Pylori-infected Adult Subjects on Proton Pump Inhibitors [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating Lactobacillus reuteri ProGastria in adults with Helicobacter pylori infection on proton pump inhibitors has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Helicobacter Pylori Infection

Drugs mentioned

• Lactobacillus reuteri ProGastria (Lactobacillus reuteri)

Snippet

Sponsor: St Marina University Hospital, Varna, Bulgaria | Conditions: Helicobacter Pylori Infection | Phase 3 | Status: COMPLETED